SHANGHAI – At China Trials 10, the optimism around the recent regulatory reforms – specifically those opening China to early stage and multiregional clinical trials – come with a hint of anxiety, as evidenced in the conference title: "Entering the New Era of China Clinical Development – Are We Ready?"